Arcutis to Present at the Goldman Sachs 41st Annual Global Health Care Conference

WESTLAKE VILLAGE, Calif., June 10, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that President and CEO Frank Watanabe will participate in a fireside chat during the Goldman Sachs 41st Annual Global Healthcare Conference Webcast taking place June 9-11, 2020.